Zivo Bioscience, Inc. SEC filings ZIVO
Zivo Bioscience, Inc. has 757 filings in SEC EDGAR's recent list, going back to Apr 20, 2000. Its latest annual report, Form ARS, was filed on Apr 25, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Mar 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 1, 2026 | — |
| 15-12G | Deregistration | Mar 31, 2026 | — |
| S-8 POS | S-8 | Mar 31, 2026 | — |
| POS AM | Filing | Mar 31, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 30, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 19, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 14, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 9, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Jan 27, 2025 | Jan 22, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 15, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 15, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Oct 18, 2024 | Oct 17, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| 8-K/A |
Amended current report
Material agreement
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jun 6, 2024 | May 31, 2024 |
| UPLOAD | Letter from the SEC | Jun 5, 2024 | — |
| CORRESP | Letter to the SEC | May 31, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| UPLOAD | Letter from the SEC | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 15, 2024 | Feb 13, 2024 |
| 25-NSE | Delisting notice | Feb 15, 2024 | — |
| 8-K |
Current report
Unregistered share sale
|
Jan 17, 2024 | Dec 5, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Jan 5, 2024 | Dec 5, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Jan 3, 2024 | Dec 5, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Dec 11, 2023 | Dec 5, 2023 |
| RW | Form rw | Dec 1, 2023 | — |
| 8-K |
Current report
Listing notice
|
Nov 27, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 22, 2023 | Nov 16, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| S-1/A | Amended registration statement | Nov 3, 2023 | — |
| S-1/A | Amended registration statement | Nov 1, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 26, 2023 | Oct 26, 2023 |
| S-1 | Registration statement | Oct 4, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 9, 2023 | Aug 4, 2023 |
| EFFECT | Filing | Aug 3, 2023 | — |
| 424B3 | Prospectus | Aug 3, 2023 | — |
| CORRESP | Letter to the SEC | Aug 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2023 | — |
| S-3 | Shelf registration | Jul 28, 2023 | — |
| D | Filing | Jul 17, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 6, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 5, 2023 | — |
| RW | Form rw | Jun 28, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Listing notice
|
May 26, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Apr 5, 2023 | Apr 3, 2023 |
| S-1 | Registration statement | Mar 22, 2023 | — |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2022 | Nov 22, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2022 | Aug 23, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 7, 2022 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Jul 5, 2022 | Jul 28, 2022 |
| 8-K | Current report | Jun 28, 2022 | Jun 22, 2022 |
| S-8 | Employee stock plan registration | Jun 22, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2022 | May 20, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2022 | Apr 19, 2022 |
| 10-K | Annual report | Apr 22, 2022 | Dec 31, 2021 |
| 10-Q/A | Amended quarterly report | Apr 21, 2022 | Sep 30, 2021 |
| 8-K |
Current report
Restatement
|
Apr 15, 2022 | Apr 13, 2022 |
| NT 10-K | Form nt10-k | Mar 31, 2022 | Dec 31, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 1, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 25, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Feb 16, 2022 | Feb 10, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 11, 2022 | Jan 10, 2022 |
| 8-K/A |
Amended current report
Auditor change
|
Dec 10, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Auditor change
|
Dec 9, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2021 | Oct 12, 2021 |
| DEFA14A | Additional proxy material | Sep 22, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2021 | Sep 16, 2021 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 16, 2021 | Nov 11, 2020 |
| DEF 14A | Proxy statement | Sep 13, 2021 | Oct 12, 2021 |
| EFFECT | Filing | Sep 3, 2021 | — |
| CORRESP | Letter to the SEC | Sep 1, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2021 | — |
| S-3 | Shelf registration | Aug 26, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 2, 2021 | May 27, 2021 |
| 424B4 | Prospectus | Jun 1, 2021 | — |
| EFFECT | Filing | May 27, 2021 | — |
| S-1MEF | Form s-1mef | May 27, 2021 | — |
| CERT | Filing | May 27, 2021 | — |
| 8-A12B | Filing | May 27, 2021 | — |
| CORRESP | Letter to the SEC | May 26, 2021 | — |
| CORRESP | Letter to the SEC | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 19, 2021 | — |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-K/A | Amended annual report | Apr 30, 2021 | Dec 31, 2020 |
| S-1/A | Amended registration statement | Apr 13, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2021 | Mar 17, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2021 | Jan 1, 2021 |
| UPLOAD | Letter from the SEC | Dec 15, 2020 | — |
| S-1 | Registration statement | Dec 9, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 17, 2020 | Nov 11, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2020 | Nov 11, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| DEFR14A | Filing | Oct 19, 2020 | — |
| PRER14A | Filing | Oct 8, 2020 | — |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Apr 29, 2020 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2020 | Mar 4, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2020 | Mar 3, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2019 | Nov 29, 2019 |
| 10-Q | Quarterly report | Oct 28, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 13, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 7, 2019 | May 1, 2019 |
| 8-K |
Current report
Other events
|
May 1, 2019 | May 1, 2019 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| 8-K |
Current report
Material agreement
|
Apr 8, 2019 | Apr 8, 2019 |
| DEFR14A | Revised definitive 14a proxy statement | Mar 25, 2019 | — |
| DEF 14A | Proxy statement | Mar 19, 2019 | Mar 18, 2019 |
| PRE 14A | Preliminary proxy statement | Feb 28, 2019 | Feb 28, 2019 |
| 10-K | Annual report | Feb 12, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Material agreement
|
Jan 7, 2019 | Dec 31, 2018 |
| UPLOAD | Letter from the SEC | Nov 26, 2018 | — |
| 8-K |
Current report
Other events
|
Nov 14, 2018 | Nov 12, 2018 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Nov 9, 2018 | Nov 7, 2018 |
| 8-K |
Current report
Other events
|
Nov 7, 2018 | Nov 7, 2018 |
| CORRESP | Letter to the SEC | Nov 1, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2018 | — |
| DEF 14A | Proxy statement | Sep 27, 2018 | Sep 26, 2018 |
| CORRESP | Letter to the SEC | Sep 25, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2018 | — |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Other events
|
May 29, 2018 | May 29, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
May 18, 2018 | May 17, 2018 |
| D | Filing | May 15, 2018 | — |
| PRE 14A | Preliminary proxy statement | Apr 30, 2018 | Apr 27, 2018 |
| 10-Q | Quarterly report | Apr 23, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Feb 21, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 12, 2018 | Jan 31, 2018 |
| 8-K |
Current report
Other events
|
Jan 10, 2018 | Jan 10, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Nov 13, 2017 | Nov 8, 2017 |
| 8-K |
Current report
Other events
|
Nov 8, 2017 | Nov 8, 2017 |
| 10-Q | Quarterly report | Oct 19, 2017 | Sep 30, 2017 |
| DEF 14A | Proxy statement | Oct 3, 2017 | Oct 3, 2017 |
| PRE 14A | Preliminary proxy statement | Sep 21, 2017 | Sep 20, 2017 |
| 8-K |
Current report
Other events
|
Sep 11, 2017 | Sep 11, 2017 |
| 10-Q | Quarterly report | Aug 11, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 12, 2017 | Mar 31, 2017 |
| 8-K/A |
Amended current report
Other events
|
May 2, 2017 | May 2, 2017 |
| 8-K |
Current report
Other events
|
May 2, 2017 | May 2, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 28, 2017 | Apr 28, 2017 |
| 8-K |
Current report
Other events
|
Apr 26, 2017 | Apr 20, 2017 |
| 10-K | Annual report | Mar 31, 2017 | Dec 31, 2016 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 6, 2017 | Mar 1, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2016 | Dec 15, 2016 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Nov 16, 2016 | Nov 9, 2016 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 8-K |
Current report
Other events
|
Nov 9, 2016 | Nov 9, 2016 |
| D | Filing | Oct 14, 2016 | — |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2016 | Sep 30, 2016 |
| DEF 14A | Proxy statement | Oct 3, 2016 | Sep 30, 2016 |
| PRER14A | Revised preliminary 14a proxy statement | Sep 26, 2016 | — |
| PRE 14A | Preliminary proxy statement | Sep 21, 2016 | Sep 21, 2016 |
| DEF 14A | Proxy statement | Sep 15, 2016 | Sep 14, 2016 |
| 10-Q | Quarterly report | Aug 12, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 13, 2016 | Mar 31, 2016 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Apr 29, 2016 |
| 10-K | Annual report | Mar 29, 2016 | Dec 31, 2015 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 15, 2016 | Mar 10, 2016 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 7, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Nov 13, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 13, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 29, 2015 | Jun 23, 2015 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZIVO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bloomfield Hills, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1101026
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (until Oct 16, 2014); WESTERN GLORY HOLE INC (until Jan 26, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.